| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nacksung Kim | |
| Jung Ha Kim | |||
| P2860 | cites work | Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 |
| Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress | Q24291525 | ||
| Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 | ||
| Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3 | Q24309262 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| NFAT: ubiquitous regulator of cell differentiation and adaptation | Q24673318 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice | Q28207641 | ||
| NFAT signaling: choreographing the social lives of cells | Q28216151 | ||
| Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway | Q28255002 | ||
| Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis | Q28267970 | ||
| Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1 | Q28273966 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| Osteoimmunology: interplay between the immune system and bone metabolism | Q28303107 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Perceptions of epigenetics | Q29547310 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Signaling to NF-kappaB | Q29547844 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| The evolution of gene regulation by transcription factors and microRNAs | Q29617552 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| Transcriptional regulation by calcium, calcineurin, and NFAT | Q29620410 | ||
| NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism | Q30157499 | ||
| NFAT and Osterix cooperatively regulate bone formation | Q31813054 | ||
| Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse | Q33646429 | ||
| Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. | Q33648289 | ||
| The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. | Q33794960 | ||
| Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts | Q34153522 | ||
| NFAT signaling in vertebrate development | Q34353096 | ||
| Requirement for NF-kappaB in osteoclast and B-cell development | Q35199657 | ||
| Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation | Q35604256 | ||
| Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor | Q51049420 | ||
| Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. | Q51547582 | ||
| Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Q52192178 | ||
| Bone and haematopoietic defects in mice lacking c-fos | Q58326969 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Pleiotropic effects of a null mutation in the c-fos proto-oncogene | Q62555352 | ||
| A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp | Q73731442 | ||
| Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc | Q74171908 | ||
| MafB negatively regulates RANKL-mediated osteoclast differentiation | Q79421924 | ||
| Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation | Q35848573 | ||
| Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation | Q36329898 | ||
| The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis | Q36371653 | ||
| I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss | Q36402985 | ||
| The role of NFAT in osteoclast formation | Q37033696 | ||
| Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis | Q37370702 | ||
| The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase | Q37647341 | ||
| MicroRNA biogenesis and regulation of bone remodeling | Q37884118 | ||
| Epigenetic regulation of osteoclast differentiation. | Q37968675 | ||
| Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos | Q38342636 | ||
| Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice | Q38359933 | ||
| RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation | Q38476064 | ||
| PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. | Q38744013 | ||
| A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. | Q40815624 | ||
| The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production | Q41065666 | ||
| An enhanced immune response in mice lacking the transcription factor NFAT1. | Q41199166 | ||
| Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 | ||
| Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation | Q45005986 | ||
| Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. | Q46375837 | ||
| Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis | Q46620740 | ||
| Calcineurin/NFAT signaling in osteoblasts regulates bone mass | Q46675973 | ||
| Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
| MicroRNA-124 regulates osteoclast differentiation | Q47983185 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 233-41 | |
| P577 | publication date | 2014-11-01 | |
| P1433 | published in | Journal of bone metabolism : JBM | Q26853865 |
| P1476 | title | Regulation of NFATc1 in Osteoclast Differentiation | |
| P478 | volume | 21 |
| Q38697843 | 1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells. |
| Q64107402 | A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats |
| Q92702961 | A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1 |
| Q64972623 | A catalog of single nucleotide changes distinguishing modern humans from archaic hominins. |
| Q36392181 | Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1. |
| Q50065451 | Alkaline Ceramidase 1 Protects Mice from Premature Hair Loss by Maintaining the Homeostasis of Hair Follicle Stem Cells |
| Q88361765 | Alveolar Bone Protective Effect of Hiziki Extracts on the Progression of Periodontitis |
| Q37377385 | Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling |
| Q59142520 | An Overview of Biomaterials in Periodontology and Implant Dentistry |
| Q89964126 | Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1 |
| Q90246307 | Anti-Osteoporotic Effects of Polysaccharides Isolated from Persimmon Leaves via Osteoclastogenesis Inhibition |
| Q90653768 | Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis |
| Q37496714 | Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L. |
| Q92187348 | Beneficial Effects of Total Phenylethanoid Glycoside Fraction Isolated from Cistanche deserticola on Bone Microstructure in Ovariectomized Rats |
| Q64237120 | Black Rice ( L.) Fermented with Attenuates Osteoclastogenesis and Ovariectomy-Induced Osteoporosis |
| Q93108880 | Bone Remodeling: Histone Modifications as Fate Determinants of Bone Cell Differentiation |
| Q36265510 | CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway |
| Q36404231 | Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB. |
| Q36356977 | Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradation |
| Q52606312 | Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway. |
| Q38913174 | DLX3 negatively regulates osteoclastic differentiation through microRNA-124. |
| Q50797973 | Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects. |
| Q47883783 | Differential intensity-dependent effects of pulsed electromagnetic fields on RANKL-induced osteoclast formation, apoptosis, and bone resorbing ability in RAW264.7 cells. |
| Q90609993 | Disulfiram suppressed ethanol promoted RANKL-induced osteoclastogenesis in vitro and ethanol-induced osteoporosis in vivo via ALDH1A1-NFATc1 axis |
| Q50437421 | Dual Role of Cyanidin-3-glucoside on the Differentiation of Bone Cells. |
| Q96950725 | Effect of echinalkamide identified from Echinacea purpurea (L.) Moench on the inhibition of osteoclastogenesis and bone resorption |
| Q37449518 | Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7. |
| Q61798625 | Epigenetic regulation of NfatC1 transcription and osteoclastogenesis by nicotinamide phosphoribosyl transferase in the pathogenesis of arthritis |
| Q89805481 | Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression |
| Q51133979 | F4/80 inhibits osteoclast differentiation via downregulation of nuclear factor of activated T cells, cytoplasmic 1. |
| Q35819965 | FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans |
| Q92253049 | Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway |
| Q90412365 | Ferryl Hemoglobin Inhibits Osteoclastic Differentiation of Macrophages in Hemorrhaged Atherosclerotic Plaques |
| Q92527785 | Forsythia suspensa Protects against Bone Loss in Ovariectomized Mice |
| Q92662248 | Fucoidan Prevents RANKL-Stimulated Osteoclastogenesis and LPS-Induced Inflammatory Bone Loss via Regulation of Akt/GSK3β/PTEN/NFATc1 Signaling Pathway and Calcineurin Activity |
| Q47595585 | Gα12 regulates osteoclastogenesis by modulating NFATc1 expression |
| Q92059937 | Heshouwu (Polygonum multiflorum Thunb.) Extract Attenuates Bone Loss in Diabetic Mice |
| Q90290403 | Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss |
| Q93185779 | Humanin suppresses receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation |
| Q36766801 | Immunology of Osteoporosis: A Mini-Review |
| Q42374255 | Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men. |
| Q57812844 | Influence of Iron on Bone Homeostasis |
| Q92273712 | Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss |
| Q57052716 | Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression |
| Q90450587 | Inhibitory Effect of Rosae Multiflorae Fructus Extracts on the Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis through Modulation of P38- and Ca2+-Mediated Nuclear Factor of Activated T-Cells Cytoplasmic 1 Expression |
| Q60928907 | Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)--1H-Indol-5-Ylacetamide) on Osteoclast Differentiation via Suppressing Cathepsin K Expression |
| Q47133316 | Interleukin-7 Induces Osteoclast Formation via STAT5, Independent of Receptor Activator of NF-kappaB Ligand |
| Q36749163 | Investigation of proteome changes in osteoclastogenesis in low serum culture system using quantitative proteomics. |
| Q64065423 | KBTBD11, a novel BTB-Kelch protein, is a negative regulator of osteoclastogenesis through controlling Cullin3-mediated ubiquitination of NFATc1 |
| Q90119594 | Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation |
| Q64110684 | Long noncoding RNAs: a missing link in osteoporosis |
| Q58588319 | Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis |
| Q64900997 | Mannan-Binding Lectin Attenuates Inflammatory Arthritis Through the Suppression of Osteoclastogenesis. |
| Q58796982 | Meta-Analysis of Genome-Wide Association Studies Identifies Novel Functional CpG-SNPs Associated with Bone Mineral Density at Lumbar Spine |
| Q42068034 | Methylation-mediated silencing of miR-124 facilitates chondrogenesis by targeting NFATc1 under hypoxic conditions |
| Q64120770 | MicroRNAs: Key Regulators to Understand Osteoclast Differentiation? |
| Q89717449 | Multi-omics Data Integration for Identifying Osteoporosis Biomarkers and Their Biological Interaction and Causal Mechanisms |
| Q39142554 | NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases |
| Q36221462 | NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-N:B and Reactive Oxygen Species Pathways |
| Q64068617 | Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis |
| Q37036135 | Osteoclasts-Key Players in Skeletal Health and Disease |
| Q89998406 | Osthole-loaded N-octyl-O-sulfonyl chitosan micelles (NSC-OST) inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in rats |
| Q90192899 | PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption |
| Q89996661 | Poncirin Inhibits Osteoclast Differentiation and Bone Loss Through Down-Regulation of NFATc1 In Vitro and In Vivo |
| Q38675617 | Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: Implication for the treatment of postmenopausal bone loss. |
| Q55410884 | Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation. |
| Q64994199 | Protocatechuic Acid Attenuates Trabecular Bone Loss in Ovariectomized Mice. |
| Q37472044 | RCANs regulate the convergent roles of NFATc1 in bone homeostasis |
| Q90567814 | Role of APD-Ribosylation in Bone Health and Disease |
| Q30009052 | Role of CrkII Signaling in RANKL-Induced Osteoclast Differentiation and Function |
| Q37148066 | STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis |
| Q99565104 | Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo |
| Q36320978 | Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells |
| Q38733018 | TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid. |
| Q64118002 | Targeted sequencing of in familial Paget's disease of bone |
| Q36613061 | The Influence of DNA Methylation on Bone Cells. |
| Q26778021 | The Multiple Roles of Microrna-223 in Regulating Bone Metabolism |
| Q42378776 | The effects of downhill and uphill exercise training on osteogenesis-related factors in ovariectomy-induced bone loss |
| Q33669039 | The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts. |
| Q41634435 | Transglutaminase 2 regulates osteoclast differentiation via a Blimp1-dependent pathway |
| Q64118707 | Turcz Inhibits the Osteoclastogenesis in RAW 264.7 Cells and Bone Loss in Ovariectomized Rat Model |
| Q42197175 | Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1. |
| Q92840590 | UHMWPE wear particles and dendritic cells promote osteoclastogenesis of RAW264.7 cells through RANK-activated NF-κB/MAPK/AKT pathways |
| Q90599354 | Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling |
| Q90294419 | Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis |
| Q90637761 | Water extract of tendril of Cucurbita Moschata Duch. suppresses RANKL-induced osteoclastogenesis by down-regulating p38 and ERK signaling |
| Q55413820 | Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice. |
| Q95522404 | [A review on microRNAs regulation in osteoclast differentiation and function] |
| Q44536102 | p-Coumaric acid, a dietary polyphenol ameliorates inflammation and curtails cartilage and bone erosion in the rheumatoid arthritis rat model. |
Search more.